Conmed (CNMD) Misses Q4 EPS by 48c

Conmed (NYSE: CNMD) reported Q4 EPS of $0.42, $0.48 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $250.9 million versus the consensus estimate of $302.51 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c